(Q28261215)

3

Linda Ottoboni

0 references

Elaine T Lim

Elaine T Lim

4

0 references

Melissa Sorosina

Melissa Sorosina

2

0 references

Federica Esposito

Federica Esposito

1

0 references

Nikolaos A. Patsopoulos

Nikolaos A Patsopoulos

Filippo Martinelli Boneschi

18

0 references

Filippo Martinelli Boneschi

21

0 references

Giancarlo Comi

19

Giancarlo Comi

0 references

Howard L. Weiner

15

Howard L Weiner

0 references

Philip L. De Jager

22

Philip L De Jager

0 references

author name string

Joseph M Replogle

5

0 references

Towfique Raj

6

0 references

Paola Brambilla

7

0 references

Giuseppe Liberatore

8

0 references

Clara Guaschino

9

0 references

Marzia Romeo

10

0 references

James M Stankiewicz

12

0 references

Vittorio Martinelli

13

0 references

Mariaemma Rodegher

14

0 references

David Brassat

16

0 references

Christophe Benoist

17

0 references

Wassim Elyaman

Determinants of interferon β efficacy in patients with multiple sclerosis

20

0 references

language of work or name

English

0 references

publication date

July 2015

0 references

published in

Annals of Neurology

0 references

volume

78

0 references

issue

1

0 references

page(s)

115-27

0 references

cites work

1 reference

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

Predicting responders to therapies for multiple sclerosis

21 January 2018

1 reference

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

21 January 2018

1 reference

Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.

21 January 2018

1 reference

Principal components analysis corrects for stratification in genome-wide association studies

21 January 2018

1 reference

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

21 January 2018

1 reference

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

Genomic control for association studies

21 January 2018

1 reference

Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes

21 January 2018

1 reference

An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity

21 January 2018

1 reference

Predicting short-term disability in multiple sclerosis.

21 January 2018

1 reference

lumi: a pipeline for processing Illumina microarray

21 January 2018

1 reference

Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.

21 January 2018

1 reference

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

21 January 2018

1 reference

TGF-beta induces IL-9 production from human Th17 cells.

21 January 2018

1 reference

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.

21 January 2018

1 reference

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

21 January 2018

1 reference

Aggregation of multiple sclerosis genetic risk variants in multiple and single case families

21 January 2018

1 reference

Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation

21 January 2018

1 reference

Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions

21 January 2018

1 reference

Functional evaluation of autism-associated mutations in NHE9.

21 January 2018

1 reference

Elevated Golgi pH impairs terminal N-glycosylation by inducing mislocalization of Golgi glycosyltransferases

21 January 2018

1 reference

Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.

21 January 2018

1 reference

Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults

21 January 2018

1 reference